Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway

Leukemia Research

Volumn 39, Issue 5, 2015, Pages 544-552

  Lin, Xiaojing ^a,b   Fang, Qin ^a   Chen, Shuya ^a,b   Zhe, Nana ^a,b   Chai, Qixiang ^a,b   Yu, Meisheng ^a,b   Zhang, Yaming ^a,b   Wang, Ziming ^a,b   Wang, Jishi ^a,b  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b Guizhou Province Laboratory of Hematopoietic Stem Cell Transplantation Centre   (China)

Author keywords

Acute myeloid leukemia; Apoptosis; Heme oxygenase 1; JNK c JUN; Signaling pathway

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA ACTIN; CYTARABINE; HEME OXYGENASE 1; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; HMOX1 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CD34 SELECTION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MOUSE; MYELOID LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL TIME; UPREGULATION; WESTERN BLOTTING; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL; FEMALE; GENETICS; HL 60 CELL LINE; MALE; MIDDLE AGED; PHYSIOLOGY; SCID MOUSE; U937 CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; DOWN-REGULATION; FEMALE; HEME OXYGENASE-1; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, SCID; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-JUN; U937 CELLS; YOUNG ADULT;

EID: 84928048078     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2015.02.009     Document Type: Article

References (37)

1. Fröhling S., Scholl C., Gilliland D.G., Levine R.L. Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005, 23(26):6285-6295.
2. Rowe J.M., Tallman M.S. How I treat acute myeloid leukemia. Blood 2010, 116(17):3147-3156.
3. Döhner H., Estey E.H., Amadori S., Appelbaum F.R., Büchner T., Burnett A.K., et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010, 115(3):453-474.
4. Sykes S.M., Lane S.W., Bullinger L., Kalaitzidis D., Yusuf R., Saez B., et al. Akt/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell 2011, 146(5):697-708.
5. Miyazaki T., Kirino Y., Takeno M., Samukawa S., Hama M., Tanaka M., et al. Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional Bach 1. Cancer Sci 2010, 101(6):1409-1416.
6. Jozkowicz A., Was H., Dulak J. Heme oxygenase-1 in tumors: is it a false friend?. Antioxid Redox Signal 2007, 9(12):2099-2117.
7. Was H., Cichon T., Smolarczyk R., Rudnicka D., Stopa M., Chevalier C., et al. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006, 169(6):2181-2198.
8. Mayerhofer M., Florian S., Krauth M.T., Aichberger K.J., Bilban M., Marculescu R., et al. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 2004, 64(9):3148-3154.
9. Mayerhofer M., Gleixner K.V., Mayerhofer J., Hoermann G., Jaeger E., Aichberger K.J., et al. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 2008, 111(4):2200-2210.
10. Rushworth S.A., MacEwan D.J. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood 2008, 111(7):3793-3801.
11. Nagai T., Kikuchi S., Ohmine K., Miyoshi T., Nakamura M., Kondo T., et al. Hemin reduces cellular sensitivity to imatinib and anthracyclins via Nrf2. J Cell Biochem 2008, 104(2):680-691.
12. Elbirt K.K., Whitmarsh A.J., Davis R.J., Bonkovsky H.L. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells: role of mitogen-activated protein kinases. J Biol Chem 1998, (15):8922-8931.
13. Alam J., Wicks C., Stewart D., Gong P., Touchard C., Otterbein S., et al. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 2000, 275(36):27694-27702.
14. Wang J.S., Singh H., Zhang F., Ishizuka T., Deng H., Kemp R., et al. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 2006, (7):962-969.
15. Ma D., Fang Q., Li Y., Wang J.S., Sun J., Zhang Y., et al. Crucial role of heme oxygenase-1 in the sensitivity of acute myeloid leukemia cell line Kasumi-1 to ursolic acid. Anticancer Drugs 2014, 25(4):406-414.
16. Shan W.L., Ma X.L. How to establish acute myeloid leukemia xenograft models using immunodeficient mice. Asian Pac J Cancer Prev 2013, 14(12):7057-7063.
17. Rosato R., Hock S., Dent P., Dai Y., Grant S. LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism. Leuk Res 2012, 36(4):491-498.
18. Tajima N., Fukui K., Uesato N., Maruhashi J., Yoshida T., Watanabe Y., et al. JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells. Cancer Sci 2010, 101(3):774-781.
19. Shang Z., Wang J., Wang D., Xiao M., Li T.J., Wang N., et al. Establishment of xenotransplantation model of human CN-AML with FLT3-ITD (mut)/NPM1 (-) in NOD/SCID mice. J Huazhong Univ Sci Technolog Med Sci 2013, 33(3):329-334.
20. Papa V., Tazzari P.L., Chiarini F., Cappellini A., Ricci F., Billi A.M., et al. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. Leukemia 2008, 22(1):147-160.
21. Wang J.S., Ma D., Li Y., Yang Y., Hu X.Y., Zhang W., et al. Targeted delivery of CYP2E1 recombinant adenovirus to malignant melanoma by bone marrow-derived mesenchymal stem cells as vehicles. Anticancer Drugs 2014, 25(3):303-314.
22. Heasman S.A., Zaitseva L., Bowles K.M., Rushworth S.A., Macewan D.J. Protection of acute myeloid leukemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxyenase-1. Oncotarget 2011, 2(9):658-668.
23. Chen S.Y., Wang J.S., Fang Q., Gao R., Shi Q.Y., Zhang H., et al. Upregulated heme oxygenase-1 expression of mouse mesenchymal stem cells resists to chemotherapy-induced bone marrow suppression. Chin Med J (Engl) 2014, 127(7):1310-1316.
24. Kanno S., Higurashi A., Watanabe Y., Shouji A., Asou K., Ishikawa M. Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines. Toxicol Lett 2004, 152(2):149-158.
25. Mitsuhashi M., Endo K., Obara K., Izutsu H., Ishida T., Chikatsu N., et al. Ex vivo simulation of the action of antileukemia drugs by measuring apoptosis-related mRNA in blood. Clin Chem 2008, 54(4):673-681.
26. Taylor C.A., Zheng Q., Liu Z., Thompson J.E. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells. Mol Cancer 2013, 12:35.
27. Rushworth S.A., Bowles K.M., Raninga P., MacEwan D.J. NF-kappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction. Cancer Res 2010, 70(7):2973-2983.
28. Noh S.J., Bae J.S., Jamiyandorj U., Park H.S., Kwon K.S., Jung S.H., et al. Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer 2013, 13:516.
29. Tsai J.R., Wang H.M., Liu P.L., Chen Y.H., Yang M.C., Chou S.H., et al. High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients. Cell Oncol (Dordr) 2012, 35(6):461-471.
30. Liu Y.S., Li H.S., Qi D.F., Zhang J., Jiang X.C., Shi K., et al. Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin. World J Gastroenterol 2014, 20(26):8572-8582.
31. Berberat P.O., Dambrauskas Z., Gulbinas A., Giese T., Giese N., Künzli B., et al. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005, 11(10):3790-3798.
32. Helbig G., Christopherson K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003, 278(24):21631-21638.
33. Rushworth S.A., Zaitseva L., Langa S., Bowles K.M., MacEwan D.J. FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism. Oncotarget 2010, 1(5):359-366.
34. Rushworth S.A., Macewan D.J. The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells. Cancers (Basel) 2011, 3(2):1605-1621.
35. Zgheel F., Alhosin M., Rashid S., Burban M., Auger C., Schini-Kerth V.B. Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1. PLoS One 2014, 9(8):e105102.
36. Dérijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76(6):1025-1037.
37. Tournier C. The 2 faces of JNK signaling in cancer. Genes Cancer 2013, 4(9-10):397-400.